158results about How to "Hydrate fast" patented technology

Mucoadhesive tablets have a convex surface, a diameter to cup depth ratio of 4-20 and a cup depth to edge thickness ratio of greater than 0.75 swiftly adheres and conforms to the contacting tissue. The tablets are used to administer actives such as, for example, benzocaine.

The present invention provides a foamed and / or aerated substrate for transmucosal and / or transdermal applications. The foamed and / or aerated substrate may be in the form of a film, sheet, strip or wafer. The foamed and / or aerated substrate is suitable for use in applications such as, for example, adhesive denture liners, tooth whitening, and smoking control / cessation. The foamed and / or aerated substrate is polymeric in nature and comprises one or more polymers and one or more foaming agents. Additionally, the foamed and / or aerated substrate may include, but not limited to, one or more plasticizers, hydrophobic barrier agents, tooth whitening agents, antioxidants, preservatives, super-disintegrants or absorbents, flavorants, deodorants, breath freshening agents, colorants, surfactants, film modifiers, cross-linking agents, antimicrobial agents, control release agents, other therapeutic agents, or any combinations thereof.

The invention discloses ultrahigh-strength concrete which comprises the following components in parts by weight: 300-350 parts of cement, 270-315 parts of composite mineral admixture, 30-35 parts of composite expanding agent, 96-112 parts of water, 680-720 parts of river sand, 1012-1080 parts of gravel, 13.2-14.0 parts of polycarboxylic acid high-efficiency water reducing agent, 4.4-4.7 parts of plastic retaining agent and 0.18-0.21 part of defoaming agent, wherein the composite mineral admixture is prepared from 42-49 parts of ore powder, 150-175 parts of fly ash, 30-35 parts of silica fume, 18-21 parts of zeolite powder and 30-35 parts of wollastonite powder. The invention is characterized in that the 60d concrete compression strength is 140-160 MPa, the 60d splitting tensile strength is 9.2-10.2 MPa, extruded concrete can achieve self-compaction effect within 3 hours, and the 14d self-shrinkage value is less than 0.05%.

Disclosed herein is a oral extended release dosage form comprising a plurality of granules of an effective amount of a pharmaceutically active compound, at least one amino acid, and an intragranular polymer in which the granule is dispersed within a hydrophilic extragranular polymer matrix which is more rapidly hydrating than the intragranular polymer. The amino acid is selected for hydropathy characteristics depending on solubility characteristics of the active compound.

Clinkered materials containing high concentrations of {(C,K,N,M)4(A,F,Mn,P,T,S)3(cl,{overscore (S)})} (crystal X), and {(C2S)3(C{overscore (S)})3 Ca(f,cl) 2} or {(C2S)3(C{overscore (S)})3Ca(f,cl)2} (crystal Y), and / or {C5S2{overscore (S)}) (crystal Z) directly from the kiln, rapidly hardening ultra-high early strength cement including these clinkered materials, methods for forming and using said compositions and the cements so produced are claimed. The methods include the steps of forming a mixture of raw material containing CaO, MgO, Al2O3, Fe2O3, TiO2, Mn2O3, SiO2, SO3, Na2O, K2O, P2O5 and F, respectively designated C, M, A, F, T, Mn, S, {overscore (S)}, N, K, P and f, and heating said mixture to an elevated temperature between 900° C. and 1,200° C.; before determining average amount of crystals X, Y, and Z. Final mixtures comprising these clinkers and hydraulic or portland type cement are made to produce cement compositions having crystal X concentrations of approximately 5% to 35% by weight, crystal Y concentrations of approximately 5% to 40% by weight, and / or crystal Z concentrations of approximately 5% to 40% by weight, with the remainder being hydraulic or portland type cement. The cements so produced are rapid hardening and exhibit high strengths ranging from 2,000 psi to 7,000 psi in one hour, 6,000 to 8,000 psi in one day and 9,000 to 12,000 psi in 28 days. They are sulfate and sea-water attack resistant and have low heats of hydration, minimal shrinkage, and high water impermeability. The methods claimed also results in significant reduction in gaseous emissions including SOx, NOx and COx.

A landfill cover composition comprising a concentrate formulated to include a hardening agent, a thickener and emulsifier, and a super absorbent polymer, mixable with water and a filler material, such as cellulose or wood fiber mulch. A mixture of water, filler material and concentrate is sprayed on the surface of a landfill refuse layer and hardened to provide at least a temporary cover as an alternative to a significantly thicker or deeper layer of conventional soil or earth cover. The biodegradable composition preferably includes Plaster of Paris and guar gum compositions and cross-linked sodium acrylate polymer fines, mixed with the filler material and water at a landfill site for reducing transportation and handling costs.

The invention provides after-sun repair serum containing dendrobium candidum. The after-sun repair serum is prepared from raw materials in parts by weight as follows: 0.2-0.9 parts of a dendrobium candidum extracting solution, 0.2-0.8 parts of passion fruit seed essential oil, 0.1-0.3 parts of shaddock peel essential oil, 0.1-0.5 parts of sodium hyaluronate, 0.5-1.0 part of trehalose, 0.1-0.3 parts of lecithin, 5-20 parts of a moisturizer, 0.5-2.5 parts of gel matrix and 95-120 parts of water. The after-sun repair serum is prepared from the dendrobium candidum extracting solution, the passionfruit seed essential oil and the shaddock peel essential oil as main functional components, thereby being capable of rapidly replenishing water, moisturizing skin, keeping skin elasticity, resisting free radicals and aging, reducing ultraviolet damage and the like.

Disclosed herein is a oral extended release dosage form comprising a plurality of granules of an effective amount of a pharmaceutically active compound, at least one amino acid, and an intragranular polymer in which the granule is dispersed within a hydrophilic extragranular polymer matrix which is more rapidly hydrating than the intragranular polymer. The amino acid is selected for hydropathy characteristics depending on solubility characteristics of the active compound.

Liposomal pharmaceutical formulations incorporating porphyrin photosensitizers useful for photodynamic therapy or diagnosis of malignant cells. The liposomal formulations comprise a porphyrin photosensitizer, particularly the hydro-mono benzoporphyrins (BPD) having light absorption maxima in the range of 670-780 nanometers, a disaccharide or polysaccharide and one or more phospholipids.